Badimon L - Search Results

1

Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI.

Vilahur G, Sutelman P, Ben-Aicha S, Mendieta G, Radiké M, Schoch L, Casaní L, Borrell-Pagés M, Padro T, Badimon L. Vilahur G, et al. Among authors: badimon l. Front Pharmacol. 2022 May 3;13:891801. doi: 10.3389/fphar.2022.891801. eCollection 2022. Front Pharmacol. 2022. PMID: 35592428 Free PMC article.

2

Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall.

Rodríguez C, Raposo B, Martínez-González J, Casaní L, Badimon L. Rodríguez C, et al. Among authors: badimon l. Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1409-14. doi: 10.1161/01.atv.0000033818.21748.99. Arterioscler Thromb Vasc Biol. 2002. PMID: 12231558

3

Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells.

Royo T, Martínez-González J, Vilahur G, Badimon L. Royo T, et al. Among authors: badimon l. Atherosclerosis. 2003 Mar;167(1):55-63. doi: 10.1016/s0021-9150(02)00393-3. Atherosclerosis. 2003. PMID: 12618268

4

Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.

Vilahur G, Baldellou MI, Segalés E, Salas E, Badimon L. Vilahur G, et al. Among authors: badimon l. Cardiovasc Res. 2004 Mar 1;61(4):806-16. doi: 10.1016/j.cardiores.2003.11.034. Cardiovasc Res. 2004. PMID: 14985078

5

A novel anti-ischemic nitric oxide donor inhibits thrombosis without modifying haemodynamic parameters.

Vilahur G, Segalés E, Casaní L, Badimon L. Vilahur G, et al. Among authors: badimon l. Thromb Haemost. 2004 May;91(5):1035-43. doi: 10.1160/TH03-12-0786. Thromb Haemost. 2004. PMID: 15116267

6

Antithrombotic effects of saratin on human atherosclerotic plaques.

Vilahur G, Duran X, Juan-Babot O, Casaní L, Badimon L. Vilahur G, et al. Among authors: badimon l. Thromb Haemost. 2004 Jul;92(1):191-200. doi: 10.1160/TH03-11-0687. Thromb Haemost. 2004. PMID: 15213861

7

Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering.

Casani L, Sanchez-Gomez S, Vilahur G, Badimon L. Casani L, et al. Among authors: badimon l. Thromb Haemost. 2005 Nov;94(5):1035-41. doi: 10.1160/TH05-04-0245. Thromb Haemost. 2005. PMID: 16363247

8

Aggregated low density lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth muscle cells.

Otero-Viñas M, Llorente-Cortés V, Peña E, Padró T, Badimon L. Otero-Viñas M, et al. Among authors: badimon l. Atherosclerosis. 2007 Oct;194(2):326-33. doi: 10.1016/j.atherosclerosis.2006.10.021. Epub 2006 Nov 28. Atherosclerosis. 2007. PMID: 17134708

9

Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.

Vilahur G, Pena E, Padró T, Badimon L. Vilahur G, et al. Among authors: badimon l. Thromb Haemost. 2007 Apr;97(4):650-7. Thromb Haemost. 2007. PMID: 17393029

10

A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.

Vilahur G, Casaní L, Badimon L. Vilahur G, et al. Among authors: badimon l. Thromb Haemost. 2007 Sep;98(3):662-9. Thromb Haemost. 2007. PMID: 17849057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters